Neuronal Ceroid Lipofuscinosis NCL5 | Animal Genetics


New Coupon

Download Coupon Here

New Equine Test

Immune-Mediated Myositis (IMM)
New test available for Quarter Horses and related breeds. Please see Immune-Mediated Myositis (IMM)

Equine Test

Equine Speed and Distance
Please see: Performance Testing

New Canine Test

Neuronal Ceroid Lipofuscinosis (NCL) in Golden Retrievers
Please see: Golden Retriever NCL

New Canine Test

Coat Color Dilution
Please see: Dilute2

New Canine Test

Pug Dog Encephalitis (PDE)
Please see: PDE

New Canine Test

Ichthyosis Test For American Bulldog
Please see: Ichthyosis Testing

New Canine Test

Dermatomyositis (DMS)
Please see: Dermatomyositis (DMS) Testing

New Canine Test

Susceptibility to Intervertebral Disc Disease (IVDD)
Please see: IVDD Testing

Equine Test

Testing for Warmblood Fragile Foal Syndrome (WFFS)
Please see: WFFS Testing

New Equine Test

Squamous Cell Carcinoma (SCC)
New test available for Horses. Please see Squamous Cell Carcinoma (SCC)

New Equine Test

Occipitoatlantoaxial Malformation Test for Arabian Horses (OAAM)
New test available for Horses. Please see Occipitoatlantoaxial Malformation (OAAM)

Early Onset Neuronal Ceroid Lipofuscinosis Type 5 in Border Collies (NCL5)


There are many forms of Neuronal Ceroid Lipofuscinosis (NCL5) that result in progressive degeneration of the central nervous system. Characteristic neurological signs of NCL include mental dullness, ataxia, loss of vision, weakness, abnormal gait, seizures, tremors, and aggressive behaviors.


NCL in Border Collies was first identified in Australia in the 1980s. Additional cases of NCL with the disease was also reported in the USA in the 1990s.


In 2005, a nonsense mutation (c.619C>T) in exon 4 in the canine CLN5 gene was reported to be linked to a specific form of Neuronal Ceroid Lipofuscinosis found in Border Collies. In 2016 NCL was diagnosed in young adult Australian Cattle Dogs. Further studies showed all affected individuals were identified as being homozygous for the nonsense mutation (c.619C>T) in exon 4, which was previously linked the NCL in Border Collies.

Acceptable Sample Types:

Animal Genetics accepts buccal swab, blood, and dewclaw samples for testing. Sample collection kits are available and can be ordered at Canine Test Now.

This Test Is Relevant For the Following Breeds:

  • Australian Cattle Dogs
  • Border Collie


Animal Genetics offers DNA testing for Neuronal Ceroid Lipofuscinosis (NCL5). The genetic test verifies the presence of the Neuronal Ceroid Lipofuscinosis (NCL5) mutation and presents results as one of the following:

NCL5/NCL5 Affected The dog carries two copies of the mutant CLN5 gene and is homozygous for NCL. The dog is affected and will always pass a copy of the mutation to its offspring.
n/NCL5 Carrier Both the normal and mutant copies of the CLN5 gene detected. Dog is a carrier for the Neuronal Ceroid Lipofuscinosis and can pass on a copy of the defective gene to its offspring 50% of the time..
n/n Clear Dog tested negative for the mutant CLN5 gene and will not pass on the defective gene to its offspring.